Ventricular Assist Devices (VAD) Market Growth by 2032 | |
Автор: doe john |
| The 2022 global size for Ventricular Assist Devices (VAD) market amounted to USD 2.24 Billion, and as per the most recent report by Reports and Data, it is anticipated to demonstrate a revenue Compound Annual Growth Rate (CAGR) of 12% throughout the forecast period. VAD, short for mechanical circulatory support devices, plays a crucial role in facilitating blood circulation from the heart’s lower chambers to the body. With an estimated 26 million people globally suffering from heart failure, the prevalence of this condition continues to increase. VADs serve as a viable alternative for individuals experiencing end-stage heart failure, offering an option when heart transplantation isn’t feasible. The market’s revenue growth is also significantly influenced by advancements in VAD technology. Substantial progress in VAD technology over the last few years has led to enhancements in device effectiveness, durability, and design. For instance, the transition from traditional pulsatile VADs to continuous-flow VADs has notably improved patient outcomes and reduced complications. Moreover, the increasing preference for less invasive surgical techniques in VAD implantation procedures is contributing to the market’s revenue growth. Surgeons are adopting minimally invasive surgical methods to implant VADs with minimal or no incisions, resulting in reduced recovery periods and fewer complications. To get sample PDF @ https://www.reportsanddata.com/download-free-sample/6166 Top Companies: • Abbott Laboratories • Bivacor Inc. • Boston Scientific Corporation • Fresenius Medical Care AG & Co. KGaA • Medtronic • St. Jude Medical, Inc. • SynCardia Systems, LLC. • Terumo Corporation • Thoratec Corporation • Abiomed, Inc. Some Key Highlights from the Report • In 2022, the largest portion of revenue in the medical field was projected to come from the Left Ventricular Assist Device (LVAD) sector. This growth is attributed to the escalating rates of heart disease and an aging demographic. An LVAD, a mechanical apparatus inserted into the left ventricle of the heart, is responsible for pumping oxygen-enriched blood throughout the body. It assists the heart when the left ventricle fails to adequately circulate blood due to heart failure or other cardiac ailments. Moreover, the notable rise in cardiac transplants and the shortage of organ donors significantly contribute to the revenue growth in this sector. • During 2022, the continuous flow segment emerged with the highest revenue share in the global VAD market. This achievement is attributed to their compact size, enhanced durability, and lower power consumption. Continuous flow VADs are implanted into the chest and connected to the aorta and left ventricle of the heart, sustaining blood circulation. These devices fulfill the need for a smaller pump, making the implantation process more comfortable for patients. Furthermore, studies have revealed that continuous flow VADs decrease the occurrence of device failure and the risk of blood clotting, ultimately improving patient outcomes. Read Full Report @ https://www.reportsanddata.com/report-detail/ventricular-assist-devices-market Based on Region market is segmented into: • North America • Europe • Asia-Pacific • South America • Middle East & Africa Product Outlook: • Left Ventricular Assist Device (LVAD) • Right Ventricular Assist Device (RVAD) • Bi-Ventricular Assist Device (Bi-VAD) Flow Outlook: • Pulsatile Flow • Continuous Flow Application Outlook: • Bridge to Transplant • Destination Therapy Request for Customization of Report@ https://www.reportsanddata.com/request-customization-form/6166 About Reports and Data Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Contact Us: John W (Head of Business Development) Reports and Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com Blogs | Press Release | Industry News | Our competencies Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports Browse More Latest Reports @ https://www.reportsanddata.com/report |
| Tweet |
 Отправить на E-mail
 Версия для печати
|
